-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Pnsr7P7ijFNq4LoIEBPf63yQDyOhxdjypX4fheGp5OTfalPdG8Wyqstnvf3vpkNG lv4dU5ccHuDBuLNIYJ0k0g== 0001181431-09-044443.txt : 20090918 0001181431-09-044443.hdr.sgml : 20090918 20090918144953 ACCESSION NUMBER: 0001181431-09-044443 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090120 FILED AS OF DATE: 20090918 DATE AS OF CHANGE: 20090918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schwieterman William D CENTRAL INDEX KEY: 0001403961 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 091076626 MAIL ADDRESS: STREET 1: C/O OXIGENE, INC., 230 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 rrd250413.xml X0303 4 2009-01-20 0 0000908259 OXIGENE INC OXGN 0001403961 Schwieterman William D C/O OXIGENE, INC. 701 GATEWAY BLVD., SUITE 210 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock, $0.01 par value per share 2009-01-20 4 A 0 1153 0.65 A 41153 D Common Stock, $0.01 par value per share 2009-03-02 4 A 0 1209 0.62 A 42362 D Common Stock, $0.01 par value per share 2009-03-16 4 A 0 1086 0.69 A 43448 D Common Stock, $0.01 par value per share 2009-03-31 4 A 0 5514 0.68 A 48962 D Common Stock, $0.01 par value per share 2009-04-16 4 A 0 961 0.78 A 49923 D Common Stock, $0.01 par value per share 2009-04-28 4 A 0 914 0.82 A 50837 D Common Stock, $0.01 par value per share 2009-05-01 4 A 0 806 0.93 A 51643 D Common Stock, $0.01 par value per share 2009-05-28 4 A 0 336 2.23 A 51979 D Common Stock, $0.01 par value per share 2009-06-29 4 A 0 323 2.32 A 52302 D Common Stock, $0.01 par value per share 2009-06-30 4 A 0 1720 2.18 A 54022 D Dr. Schwieterman received shares of OXiGENE common stock ("Shares") pursuant to the OXiGENE, Inc. Amended and Restated Director Compensation Policy (the "Policy") in lieu of payment of compensation for Board of Directors and Committee services for the quarter ended March 31, 2009. Dr. Schwieterman was entitled to receive $750 for attending a Board of Directors meeting held on January 20, 2009. The closing price per share on the grant date for the Shares issued was $0.65. Dr. Schwieterman received Shares pursuant to the Policy in lieu of payment of compensation for Board of Directors and Committee services for the quarter ended March 31, 2009. Dr. Schwieterman was entitled to receive $750 for attending a Board of Directors meeting held on March 2, 2009. The closing price per share on the grant date for the Shares issued was $0.62. Dr. Schwieterman received Shares pursuant to the Policy in lieu of payment of compensation for Board of Directors and Committee services for the quarter ended March 31, 2009. Dr. Schwieterman was entitled to receive $750 for attending a Board of Directors meeting held on March 16, 2009. The closing price per share on the grant date for the Shares issued was $0.69. Dr. Schwieterman received Shares pursuant to the Policy in lieu of payment of compensation for Board of Directors and Committee services for the quarter ended March 31, 2009. Dr. Schwieterman was entitled to receive $3,750 during this quarter for retainer fees for Board of Directors service. The closing price per share on the grant date for the Shares issued was $0.68. Dr. Schwieterman received Shares pursuant to the Policy in lieu of payment of compensation for Board of Directors and Committee services for the quarter ended June 30, 2009. Dr. Schwieterman was entitled to receive $750 for attending a Board of Directors meeting held on April 16, 2009. The closing price per share on the grant date for the Shares issued was $0.78. Dr. Schwieterman received Shares pursuant to the Policy in lieu of payment of compensation for Board of Directors and Committee services for the quarter ended June 30, 2009. Dr. Schwieterman was entitled to receive $750 for attending a Board of Directors meeting held on April 28, 2009. The closing price per share on the grant date for the Shares issued was $0.82. Dr. Schwieterman received Shares pursuant to the Policy in lieu of payment of compensation for Board of Directors and Committee services for the quarter ended June 30, 2009. Dr. Schwieterman was entitled to receive $750 for attending a Board of Directors meeting held on May 1, 2009. The closing price per share on the grant date for the Shares issued was $0.93. Dr. Schwieterman received Shares pursuant to the Policy in lieu of payment of compensation for Board of Directors and Committee services for the quarter ended June 30, 2009. Dr. Schwieterman was entitled to receive $750 for attending a Board of Directors meeting held on May 28, 2009. The closing price per share on the grant date for the Shares issued was $2.23. Dr. Schwieterman received Shares pursuant to the Policy in lieu of payment of compensation for Board of Directors and Committee services for the quarter ended June 30, 2009. Dr. Schwieterman was entitled to receive $750 for attending a Board of Directors meeting held on June 29, 2009. The closing price per share on the grant date for the Shares issued was $2.32. Dr. Schwieterman received Shares pursuant to the Policy in lieu of payment of compensation for Board of Directors and Committee services for the quarter ended June 30, 2009. Dr. Schwieterman was entitled to receive during this quarter $3,750 for retainer fees for Board of Directors service. The closing price per share on the grant date for the Shares issued was $2.18. /s/ Asya S. Alexandrovich, Attorney-in-fact 2009-09-18 -----END PRIVACY-ENHANCED MESSAGE-----